Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Proteome (PRM) Share News

IN BRIEF: Proteome Sciences repays GBP824,400 loan in full to Vulpes

1st Jun 2023 16:43

Proteome Sciences PLC - London-based drug development services provider - Says it has repaid in full its outstanding loan and associated interest, totalling GBP824,424, to Vulpes Investment Management Private Ltd, as originally announced in July 2018 and amended in March last year. Read More

TRADING UPDATES: Proteome Sciences revenue up; Mpac sees improved 2023

17th May 2023 14:45

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

Proteome Sciences expanding to US with San Diego facility

12th May 2023 10:23

(Alliance News) - Drug development services provider Proteome Sciences PLC said it is expanding its proteomics services to the US, opening a facility in San Diego. Read More

Proteome Sciences full-year revenue rises; profit multiplies

4th Apr 2023 10:16

(Alliance News) - Proteome Sciences PLC on Tuesday said revenue was up by half, and profit multiplied in 2022. Read More

AIM WINNERS & LOSERS: Mosman wins sacred site certificate at Amadeus

20th Feb 2023 10:34

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday. Read More

Proteome Sciences shares surge after strong growth in 2022

20th Feb 2023 10:24

(Alliance News) - Proteome Sciences PLC on Monday said it has experienced strong growth in both its services and TMT business, with a strong forward order book secured. Read More

IN BRIEF: Proteome Sciences reaches "sales milestone" from contract

5th Jan 2023 10:45

Proteome Sciences PLC - drug development services provider - Achieves "cumulative sales milestone" with life sciences company Thermo Fisher Scientific Inc. Says a payment of GBP870,000 has been received by the company and will be recognised in the 2022 financial year. Proteome Sciences has an exclusive licence and distributor agreement with Thermo Scientific. Read More

IN BRIEF: Proteome Sciences hires Abdelghani Omari as new CFO

18th Aug 2022 09:41

Proteome Sciences PLC - drug development services provider - Says it has hired Abdelghani Omari as its new chief financial officer, effective on September 1. Says he will also become the director of the company. Proteome says Omari will join from speciality pharmaceutical company Paion AG, where he has been the chief financial officer since 2014. Read More

Proteome Sciences shares rise 10% after swing to interim profit

4th Aug 2022 12:33

(Alliance News) - Proteome Sciences PLC on Thursday said it swung to an interim profit in the first half of 2022 on the strength of its TMT reagents. Read More

TRADING UPDATES: Ensilica expects annual profit ahead of expectations

3rd Aug 2022 15:57

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

TRADING UPDATES: Proteome set for profit rise; Kromek expects loss

16th May 2022 16:20

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: Proteome Sciences secures contract with US academic group

12th May 2022 11:14

Proteome Sciences PLC - Drug development services provider - Secures a contract from major US academic group to evaluate changes on the proteome and phospho-proteome of tissue and blood samples taken from people with and without a neurodegenerative disease. The contract's value exceeds GBP500,000. Proteome refers to entire set of proteins in a cell or organism. Read More

AIM WINNERS & LOSERS: Arc Minerals "turning point"; Titon posts loss

12th May 2022 10:47

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday. Read More

DIRECTOR DEALINGS: Departing D4T4 co-founder sells GBP900,000 worth

22nd Apr 2022 12:01

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and Friday and not separately reported by Alliance News: Read More

TRADING UPDATES: Impellam and Maintel in profit; Curtis Banks prospers

31st Mar 2022 13:04

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

IN BRIEF: Proteome Sciences amends GBP1 million loan with Vulpes

30th Mar 2022 19:23

Proteome Sciences PLC - drug development services provider - Amends GBP1 million loan with Vulpes Investment Management Private Ltd, which was signed in the summer of 2018. Accrued interest now repayable on June 30, 2023, extended from May 1, 2022. Notes GBP700,000 is currently drawn on facility. Read More

FTSE 100 Latest

Value8,275.66

Change0.00